MedTrace Logo

Impact of Implantation of an LAA Occluder on ANP and BNP Level and Quality of Life

NCT03085667 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2020-03-06

No results posted yet for this study

Summary

Closure of the LAA by several devices is a alternative therapy to oral anticoagulation in patients with Atrail fibrillation. Nothing is known about the acute influence of a device closure of the LAA on the secretion of ANB nad BNP hormones. Therefore aim of our study is to measure ANB and BNP levvels before and after Implantation of an LAA closure device.

Conditions

Sponsors & Collaborators

  • University of Leipzig

    lead OTHER

Principal Investigators

  • Sven Möbius-Winkler, MD, PhD · University of Leipzig

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2015-01-31
Completion
2015-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03085667 on ClinicalTrials.gov